WNK463 is an oral WNK kinase inhibitor for WNK1, WNK2, WNK3, and WNK4 IC50 The values are 5 nM, 1 nM, 6 nM, and 9 nM, respectively.
Tricosadiynoic acid, 10,12-Tricosadiynoic acid, is A highly specific, selective, high-affinity acyl-coa oxidase-1 (ACOX1) inhibitor with oral activity. Tricosadiynoic acid can improve mitochondrial lipid and ROS metabolism and can be used to study metabolic diseases caused by high fat diet or obesity.
Tricosadiynoic acid, 10,12-Tricosadiynoic acid, is A highly specific, selective, high-affinity acyl-coa oxidase-1 (ACOX1) inhibitor with oral activity. Tricosadiynoic acid can improve mitochondrial lipid and ROS metabolism and can be used to study metabolic diseases caused by high fat diet or obesity.
NPX800 is an oral HSF1 inhibitor of FIC. NPX800 has the potential to be used in cancer research.
NPX800 is an oral HSF1 inhibitor of FIC. NPX800 has the potential to be used in cancer research.
CD38 inhibitor 1 (COMPOUND 78c, CD38-in-78C) was an effective INHIBITOR of CD38, with IC50 of 7.3 nM and 1.9 nM for human AND mouse CD38 respectively.
CD38 inhibitor 1 (COMPOUND 78c, CD38-in-78C) was an effective INHIBITOR of CD38, with IC50 of 7.3 nM and 1.9 nM for human AND mouse CD38 respectively.
CD38 inhibitor 1 (COMPOUND 78c, CD38-in-78C) was an effective INHIBITOR of CD38, with IC50 of 7.3 nM and 1.9 nM for human AND mouse CD38 respectively.
CD38 inhibitor 1 (COMPOUND 78c, CD38-in-78C) was an effective INHIBITOR of CD38, with IC50 of 7.3 nM and 1.9 nM for human AND mouse CD38 respectively.
Milademetan (DS-3032) is a specific, orally active MDM2 inhibitor for the study of acute myeloid leukemia and solid tumors.
Milademetan (DS-3032) is a specific, orally active MDM2 inhibitor for the study of acute myeloid leukemia and solid tumors.
Phosal 50 PG is a standardized phosphatidylcholine concentrate, used in some lipid-based formulations to improve the absorption, effectiveness, and therapeutic index of the active ingredients.